BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 27, 2025
Home » Authors » Nuala Moran

Articles by Nuala Moran

CeNeS Moving To Alternative Exchange As Market Cap Dips

July 9, 2003
By Nuala Moran

UK Consolidation Continues As British Biotech, Vernalis Merging

July 7, 2003
By Nuala Moran
LONDON - Consolidation of UK biotechnology continues apace with the announcement that British Biotech plc will take over Vernalis plc in a £48 million (US$79.7 million) all-share deal that comes just three months after British Biotech's takeover of RiboTargets Holdings plc. (BioWorld Today)
Read More

UK Consolidation Continues As British Biotech, Vernalis Merging

July 7, 2003
By Nuala Moran
LONDON - Consolidation of UK biotechnology continues apace with the announcement that British Biotech plc will take over Vernalis plc in a £48 million (US$79.7 million) all-share deal that comes just three months after British Biotech's takeover of RiboTargets Holdings plc. (BioWorld Today)
Read More

U.S. Must Get Behind Stem Cell Research For Science To Take Off

July 2, 2003
By Nuala Moran

FDA Commissioner Spells Out Plans For Shoring Up Agency

July 2, 2003
By Nuala Moran

UK Government Initiates Broad, £50M Program In Area Of Genetics

July 2, 2003
By Nuala Moran
LONDON - The UK government announced a £50 million (US$83 million) program over the next three years to expand the use of genetic testing in the National Health Service (NHS), with the aim of making the UK a leader in genetics-based health care. (BioWorld International)
Read More

FDA Commissioner Spells Out Plans For Shoring Up Agency

July 2, 2003
By Nuala Moran

U.S. Must Get Behind Stem Cell Research For Science To Take Off

July 2, 2003
By Nuala Moran

UK Government Initiates Broad, £50M Program In Area Of Genetics

July 2, 2003
By Nuala Moran
LONDON - The UK government announced a £50 million (US$83 million) program over the next three years to expand the use of genetic testing in the National Health Service (NHS), with the aim of making the UK a leader in genetics-based health care. (BioWorld International)
Read More

Bush Blames Europeans For Contributing To World Famine

June 25, 2003
By Nuala Moran
Previous 1 2 … 465 466 467 468 469 470 471 472 473 … 527 528 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing